Selective Analysis of Dopamine Receptor Antagonist LE300 and its N-Methyl Metabolite in Mouse Sera at the Trace Level by HPLC–Fluorescence Detection

Abstract A highly selective, sensitive, and reliable high-performance liquid chromatography (HPLC) method was developed and validated for the simultaneous determination of a novel type of dopamine receptor antagonist LE300 and its N-methyl metabolite in mouse sera. LE300, its N-methyl metabolite, and verapamil (an internal standard) were detected using excitation and emission wavelengths of 275 and 340 nm, respectively. HPLC analysis using a deproteinization procedure was performed by injecting an aliquot of the supernatant into the chromatographic system. Chromatographic separation was achieved on a reversed-phase Spherisorb Cyano (CN) column with a mobile phase consisting of acetonitrile:50 mM phosphate buffer pH 3.5 (70:30, v/v) pumped at a flow rate of 1.0 mL $ min^{−1} $. Regression analyses showed excellent linearity (r = 0.999) for concentrations of LE300 ranging from 4 to 500 ng $ mL^{−1} $ and for concentrations of its N-methyl metabolite of 6–600 ng $ mL^{−1} $. The HPLC-FLD method had limits of detection of 1.6 ng $ mL^{−1} $ for LE300 and 2.4 ng $ mL^{−1} $ for its N-methyl metabolite in mouse sera. The precision results, expressed as the intraday and interday relative standard deviation (RSD) values, ranged from 0.65 to 2.85 % (repeatability) and from 0.37 to 2.62 % (intermediate precision) for LE300 and its N-methyl metabolite, respectively; these values are in line with ICH guidelines. The assay was successfully applied in a pharmacokinetic study. The mean values of Tmax and Cmax were 2 h and 25.03 ± 5.60 ng $ mL^{−1} $ for LE300 and 3 h and 19.92 ± 2.88 ng $ mL^{−1} $ for its N-methyl metabolite, respectively..

Medienart:

Artikel

Erscheinungsjahr:

2015

Erschienen:

2015

Enthalten in:

Zur Gesamtaufnahme - volume:78

Enthalten in:

Chromatographia - 78(2015), 9-10 vom: 21. März, Seite 655-661

Sprache:

Englisch

Beteiligte Personen:

Hefnawy, Mohamed [VerfasserIn]
Alanazi, Amer [VerfasserIn]
Abounassif, Mohammed [VerfasserIn]
Mohammed, Mostafa [VerfasserIn]
Al-Swaidan, Ibrahim [VerfasserIn]
Attia, Sabry [VerfasserIn]
Mostafa, Gamal [VerfasserIn]
El-Subbagh, Hussein [VerfasserIn]
Lehmann, Jochen [VerfasserIn]

Links:

Volltext [lizenzpflichtig]

Themen:

Fluorescence detection
HPLC
LE300
Pharmacokinetics
Trace analysis

RVK:

RVK Klassifikation

Anmerkungen:

© Springer-Verlag Berlin Heidelberg 2015

doi:

10.1007/s10337-015-2879-x

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

OLC2044361647